BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Housman TS, Williford PM, Feldman SR, Teuschler HV, Fleischer AB Jr, Goldman ND, Balkrishnan R, Chen GJ. Nonmelanoma skin cancer: an episode of care management approach. Dermatol Surg 2003;29:700-11. [PMID: 12828693 DOI: 10.1046/j.1524-4725.2003.29185.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lane JE, Kent DE. Surgical Margins in the Treatment of Nonmelanoma Skin Cancer and Mohs Micrographic Surgery. Current Surgery 2005;62:518-26. [DOI: 10.1016/j.cursur.2005.01.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
2 Briesacher BA, Tjia J, Doubeni CA, Chen Y, Rao SR. Methodological issues in using multiple years of the Medicare current beneficiary survey. Medicare Medicaid Res Rev 2012;2:002. [PMID: 24800135 DOI: 10.5600/mmrr.002.01.a04] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
3 Thompson BS, Pandeya N, Olsen CM, Dusingize JC, Green AC, Neale RE, Whiteman DC. Keratinocyte cancer excisions in Australia: Who performs them and associated costs. Australas J Dermatol 2019;60:294-300. [PMID: 31012087 DOI: 10.1111/ajd.13056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Burns EM, Tober KL, Riggenbach JA, Schick JS, Lamping KN, Kusewitt DF, Young GS, Oberyszyn TM. Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinoma. Carcinogenesis 2013;34:370-7. [PMID: 23125227 DOI: 10.1093/carcin/bgs349] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
5 Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. Journal of the American Academy of Dermatology 2005;53:320-8. [DOI: 10.1016/j.jaad.2005.03.043] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 5.2] [Reference Citation Analysis]
6 Fernández-jorge B, Peña-penabad C, Vieira V, Paradela S, Rodríguez-lozano J, Fernández-entralgo A, García-silva J, Fonseca E. Outpatient dermatology major surgery: a 1-year experience in a Spanish tertiary hospital. J Eur Acad Dermatol Venerol 2006;20:1271-6. [DOI: 10.1111/j.1468-3083.2006.01789.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
7 Glanz K, Steffen AD, Schoenfeld E, Tappe KA. Randomized trial of tailored skin cancer prevention for children: the Project SCAPE family study. J Health Commun 2013;18:1368-83. [PMID: 23806094 DOI: 10.1080/10810730.2013.778361] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
8 Prasad NB, Fischer AC, Chuang AY, Wright JM, Yang T, Tsai HL, Westra WH, Liegeois NJ, Hess AD, Tufaro AP. Differential expression of degradome components in cutaneous squamous cell carcinomas. Mod Pathol 2014;27:945-57. [PMID: 24356192 DOI: 10.1038/modpathol.2013.217] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
9 Gaffney DC, Soyer HP, Simpson F. The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target: EGF receptor targeting in SCC. Australasian Journal of Dermatology 2014;55:24-34. [DOI: 10.1111/ajd.12025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
10 Tarallo M, Cigna E, Frati R, Delfino S, Innocenzi D, Fama U, Corbianco A, Scuderi N. Metatypical basal cell carcinoma: a clinical review. J Exp Clin Cancer Res 2008;27:65. [PMID: 18992138 DOI: 10.1186/1756-9966-27-65] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
11 Higashi MK, Veenstra DL, Langley PC. Health economic evaluation of non-melanoma skin cancer and actinic keratosis. Pharmacoeconomics 2004;22:83-94. [PMID: 14731050 DOI: 10.2165/00019053-200422020-00002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
12 Heckman CJ. Enhancing skin cancer screening through behavioral intervention. JAMA Dermatol 2014;150:363-5. [PMID: 24553600 DOI: 10.1001/jamadermatol.2013.9311] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Bernard P, Dupuy A, Brun P, Sasko A, Duru G, Nicoloyannis N, Decuypere L, Grob J. Évaluation médico-économique de la prise en charge des carcinomes basocellulaires superficiels et des kératoses actiniques multiples par les dermatologues français. Annales de Dermatologie et de Vénéréologie 2007;134:527-33. [DOI: 10.1016/s0151-9638(07)89263-5] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
14 Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2010;8:268-274. [PMID: 20005977 DOI: 10.1016/j.cgh.2009.11.024] [Cited by in Crossref: 189] [Cited by in F6Publishing: 175] [Article Influence: 15.8] [Reference Citation Analysis]